0000000001091122

AUTHOR

L. Lentini

showing 5 related works from this author

The retinoblastoma paradigm revisited

2008

Background: Retinoblastoma (Rb) is the most common primary malignant intraocular tumour in childhood. The "two hit" theory, formulated by Knudson in 1971 to explain the variegated clinical expression of the disease, led to the discovery of the so called tumour suppressor genes and the identification of the Rb1 as the prototype of such genes. Mutations of the Rb1 gene are now commonly believed to be the "cause" retinoblastoma, although epidemiological, clinical, and biological evidences argue against it. Material/Methods: The Authors have performed a systematic review of available data concerning clinical and diagnostic aspects of retinoblastoma, including molecular genetics. Meta analysis o…

Settore BIO/18 - GeneticaRetinoblastomacancer geneticsaneuploidyMutationAge FactorsRetinoblastomaHumansInfant
researchProduct

Translational Readthrough Inducing Drugs (TRIDs): a study of biodistribution evaluation in mice models

nonsense mutationSettore CHIM/06 - Chimica OrganicaTRIDReadthrough
researchProduct

Integrated computational and experimental approaches for the identification of new molecules with readthrough activity on premature termination codon…

2015

cystic fibrosiscomputational approaches; readthrough; premature stop codon; cystic fibrosisreadthroughpremature stop codoncomputational approache
researchProduct

Novel molecules for the readthrough of PTCs in biological model systems and in cystic fibrosis cells

2016

readthrough; premature stop codons; PTC; cystic fibrosis; novel moleculesnovel moleculesPTCreadthroughpremature stop codoncystic fibrosi
researchProduct

Optimization of a new lead promoting the readthrough of the nonsense mutations for CFTR rescue in human CF cells

2017

Optimization of a new lead promoting the readthrough of the nonsense mutations for CFTR rescue in human CF cells Laura Lentini, Raffaella Melfi, Sara Baldassano, Marco Tutone, Aldo Di Leonardo, Andrea Pace, Ivana Pibiri Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo Background and rationale Cystic Fibrosis patients with nonsense mutations in the CFTR gene have a more severe form of the disease. Nonsense mutations represent about 10% of the mutations that affect the CFTR gene and they are frequently associated to the classical F508 mutation (1). A potential treatment for this genetic alteration is to promote the translationa…

Settore BIO/18 - Genetica-Fluorinated heterocycles -Nonsense Mutations -Premature stop codon -ReadthroughSettore BIO/11 - Biologia MolecolareSettore CHIM/06 - Chimica OrganicaSettore BIO/09 - FisiologiaSettore CHIM/08 - Chimica Farmaceutica
researchProduct